Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Menno A. W. G. van der Hoorn"'
Autor:
Roel Willemze, Pauline Meij, J.H. Frederik Falkenburg, Linda Cox, Rian Bongaerts, Erik W.A. Marijt, Amon R. Wafelman, Inge Jedema, Menno A. W. G. van der Hoorn
Publikováno v:
Haematologica, 97(8), 1205-1208
Since HA-1-specific T cells have been shown to make a significant contribution to the clinical responses in patients with relapsed leukemia, we investigated the feasibility of adoptive transfer of in vitro induced HA-1-specific CD8 positive T cells t
Autor:
Nikolai Schwabe, Menno A. W. G. van der Hoorn, Michel G.D. Kester, J.H. Frederik Falkenburg, Marieke Griffioen, H. M. Esther van Egmond, Mirjam H.M. Heemskerk, Roel Willemze, Renate S. Hagedoorn, Helen E. Barnby-Porritt
Publikováno v:
Haematologica. 93:1535-1543
Background Donor lymphocyte infusion is an effective form of adoptive immunotherapy for hematologic malignancies after allogeneic stem cell transplantation. Graft-versus-host disease, however, often develops due to recognition of ubiquitously-express
Autor:
Roel Willemze, J.H. Frederik Falkenburg, Manja Hoogeboom, Renate S. Hagedoorn, Lars T. van der Veken, Menno A. W. G. van der Hoorn, Michel G.D. Kester, Mirjam H.M. Heemskerk
Publikováno v:
Blood. 109:235-243
Genetic engineering of T lymphocytes is an attractive strategy to specifically redirect T-cell immunity toward viral infections and malignancies. We previously demonstrated redirected antileukemic reactivity of cytomegalovirus (CMV)–specific T cell
Autor:
Roelof A. de Paus, Mirjam H.M. Heemskerk, Els Goulmy, J.H. Frederik Falkenburg, Roel Willemze, Menno A. W. G. van der Hoorn, Michel G.D. Kester, Manja Hoogeboom
Publikováno v:
Blood. 102:3530-3540
Donor-derived T lymphocytes directed against minor histocompatibility antigens (mHags) exclusively expressed on cells of the hematopoietic lineages can eliminate hematologic malignancies. Transfer of T-cell receptors (TCRs) directed against these mHa
Autor:
Freke M. Kloosterboer, Mirjam H.M. Heemskerk, Jan W. Drijfhout, Menno A. W. G. van der Hoorn, Michel G.D. Kester, Simone A. P. van Luxemburg-Heys, Manja Hoogeboom, Tuna Mutis, Els Goulmy, W. A. Erik Marijt, J. H. Frederik Falkenburg, Roel Willemze, Jon J. van Rood
Publikováno v:
Proceedings of the National Academy of Sciences. 100:2742-2747
Donor lymphocyte infusion (DLI) into patients with a relapse of their leukemia or multiple myeloma after allogeneic stem cell transplantation (alloSCT) has been shown to be a successful treatment approach. The hematopoiesis-restricted minor histocomp
Autor:
Hanneke C. Kluin-Nelemans, Shama L. van Zelderen-Bhola, Menno A. W. G. van der Hoorn, J.H. Frederik Falkenburg, Roel Willemze, Rolf E. Brouwer
Publikováno v:
Brouwer, R E, Van Der Hoorn, M, Kluin-Nelemans, H C, Van Zelderen-Bhola, S, Willemze, R & Falkenburg, J H F 2000, ' The generation of dendritic-like cells with increased allostimulatory function from acute myeloid leukemia cells of various FAB subclasses ', Human Immunology, vol. 61, no. 6, pp. 565-574 . https://doi.org/10.1016/S0198-8859(00)00111-7
Human Immunology, 61(6), 565-574. Elsevier Inc.
Human Immunology, 61(6), 565-574. Elsevier Inc.
To increase the immunogenicity of leukemic cells, attempts were made to generate dendritic-like antigen presenting cells (DC) from AML blasts from 14 patients with AML FAB classifications M0-M5. Leukemic cells were cultured in the presence or absence
Autor:
J.H. Frederik Falkenburg, Jeroen van Bergen, Mirjam H.M. Heemskerk, Maria Diez Campelo, Menno A. W. G. van der Hoorn, H. M. Esther van Egmond, Roel Willemze, Lars T. van der Veken, Renate S. Hagedoorn
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950). 182(1)
Killer Ig-like receptors (KIR) are expressed by human NK cells and T cells. Although Ag-specific cytolytic activity and cytokine production of KIR+ T cells can be inhibited by KIR ligation, the effect of KIR on proliferation is unclear. KIR+ T cells
Autor:
J.H. Frederik Falkenburg, Menno A. W. G. van der Hoorn, Michel G.D. Kester, Renate S. Hagedoorn, Roelof Willemze, H. M. Esther van Egmond, Mirjam H.M. Heemskerk, Marieke Griffioen
Publikováno v:
Blood. 110:2594-2594
Patients with relapsed hematological malignancies after allogeneic stem cell transplantation (alloSCT) can be successfully treated by donor lymphocyte infusions (DLI). Since DLI consists of a variety of T cells with different specificities, the benif
Autor:
Erik W.A. Marijt, Roelof Willemze, J.H. Frederik Falkenburg, Menno A. W. G. van der Hoorn, Michel G.D. Kester, Avital L. Amir, Mirjam H.M. Heemskerk
Publikováno v:
Blood. 108:5164-5164
HLA mismatched Stem Cell Transplantation (SCT) can be performed in patients with leukemia if no HLA identical donor can be found. Although HLA class I is expressed by almost all recipient cells and the frequency of allo-HLA reactive T-cells is high i
Autor:
Marieke Griffioen, H. M. Esther van Egmond, Mirjam H.M. Heemskerk, Renate S. Hagedoorn, Menno A. W. G. van der Hoorn, Michel G.D. Kester, J.H. Frederik Falkenburg
Publikováno v:
Blood. 106:5529-5529
Patients with hematological malignancies can be successfully treated by T cell-depleted allogeneic stem cell transplantation (alloSCT) followed by donor lymphocyte infusion (DLI). Failure of some relapsed hematological malignancies to respond to DLI